Beauty Farm Medical and Health Industry Inc. will hold its 2026 annual general meeting (AGM) on 26 June 2026 at 9:30 a.m. in Hong Kong’s The Center, 62nd Floor, New York Meeting Room, 99 Queen’s Road Central. Shareholders are asked to consider 13 resolutions, including the following key items:

1. Financial Statements and Auditor’s Report • Adoption of the audited consolidated financial statements and the directors’ and auditor’s reports for the year ended 31 December 2025.

2. Board Composition • Re-election of five directors: – Mr Lian Songyong as Executive Director and Vice Chairman. – Ms Li Fangyu, Mr Gao Jianming and Ms Yi Lin as Non-executive Directors. – Mr Liu Teng as Independent Non-executive Director. • Authorisation for the board to determine directors’ remuneration.

3. Dividend Proposal • Declaration of a final dividend of HK$0.72 per share for FY 2025.

4. Auditor Appointment • Re-appointment of PricewaterhouseCoopers as external auditor, with authority for the board to fix its remuneration.

5. Share Capital Mandates • General mandate permitting the board to repurchase up to 10% of the Company’s issued shares (excluding any treasury shares). • General mandate authorising the board to allot, issue and deal with new shares—plus any sale or transfer of treasury shares—up to 20% of the issued share capital (excluding treasury shares). • Extension of the issue mandate by the number of shares repurchased under the buy-back mandate.

6. Constitutional Update • Special resolution to adopt the Third Amended and Restated Memorandum and Articles of Association, replacing the current version.

Proxy instructions require submission to Computershare Hong Kong Investor Services Limited by 9:30 a.m. on 24 June 2026 (Hong Kong time). Shareholders may appoint multiple proxies, including the AGM chairman by default, and can vote in person if desired.